No abstract available.
Neck* ; Urinary Bladder* ; Urinary Incontinence*

No abstract available.
Carcinoma, Renal Cell*

No abstract available.
Uterus*

No abstract available.
Humans ; Prednisolone* ; Prostate* ; Prostatic Neoplasms*

PURPOSE: We evaluated the effects of amitriptyline in patients with urinary frequency or pelvic pain syndrome and compared with propiverine hydrochloride (BUP-4(R)) and diazepam (Valium(R)). MATERIALS AND METHODS: One-hundred and sixty-eight patients with urinary frequency or pain were included and 38 out of 168 patients were lost to follow up. The patients with interstitial cystitis, UTI and neurogenic bladder were excluded. Amitriptyline group were instructed to take 25mg to 75mg of amitriptyline before bed. Propiverine hy drochloride and diazepam group were instructed to take 20mg, 4-6mg before bed, respectively. The clinical effects and side effects were evaluated after 4 weeks of medication. RESULTS: In the amitriptyline group, 73.1% in 78 patients with frequency, 68.3% in 60 pain, 65.6% in 32 nocturia, 53.8% in 26 weak urinary stream, 53.8% in 13 dysuria, 72.7% in 11 urgency showed symptom improvement. Urinary frequency and pain score were significantly decreased in the amitriptyline group. In the propiverine hydrochloride group, 66.7% in 21 patients with frequency, 38.8% in 18 pain showed symptom improvement. In the diazepam group, 37.5% in 24 patients with frequency, 31.3% in 16 pain showed symptom improvement. Side effects of amitriptyline had appeared in 24 (27.6%) out of 87 patients; 17 cases of dry mouth, 10 drowsiness, 2 agitation, 2 nausea, 1 constipation and 1 skin rash. CONCLUSIONS: Amitriptyline is useful in vague voiding symptoms especially in urinary frequency and chronic pelvic pain syndrome. It is equally effective in both men and women. Side effects are minimal and tolerable. A double-blind placebo-controlled trial is necessary for general acceptance in the future.
Amitriptyline* ; Constipation ; Cystitis, Interstitial ; Diazepam ; Dihydroergotamine ; Dysuria ; Exanthema ; Female ; Humans ; Lost to Follow-Up ; Male ; Mouth ; Nausea ; Nocturia ; Pelvic Pain* ; Rivers ; Sleep Stages ; Urinary Bladder, Neurogenic

No abstract available.
Bacillus* ; Humans ; Urinary Bladder Neoplasms* ; Urinary Bladder*

Patients with advanced urothelial tumors that relapse or persist following conventional therapy have poor prognosis. Management of the patients with recurrent local or disseminated urothelial tumors presents a difficult clinical problems. In 1985 Sternberg et al reported 71% of significant tumor regression and 50% of complete clinical remission with M-VAC (methotrexate, vinblastine, doxorubicin and Cisplatin) combination chemotherapy for treatment of advanced urothelial transitional cell carcinomas. Herein, we have experienced 13 cases of M-VAC combination chemotherapy in advanced urothelial tumors. Complete and partial remission was in achieved 46.2 per cent of the patients clinically, while 15.4 percent had a minor response and 38.4 per cent had progression with median survivals of 11.5, 8.5 and 7.4 months. Toxicity was significant. 15.4 per cent of the patients having experienced nadir sepsis, 30.8 per cent mucositis and 7.6 per cent cardiac toxicity. Median cycle length varied from 31.6 to 41.7 days for the first and 5th cycle respectively. This regimen has been efficacious in selected patients with advanced urothelial tumors.
Carcinoma, Transitional Cell ; Doxorubicin* ; Drug Therapy, Combination ; Humans ; Mucositis ; Prognosis ; Recurrence ; Sepsis ; Vinblastine*

The incidence of impalpable testis is approximately 20 percent of undescended testis population and some may possess vascular pedicle shortening that prohibits scrotal placement in one stage orchiopexy. From July 1987 through April 1988, 12 patients with 17 impalpable testicles were explored by lower midline incision and the following results were obtained : 1. We could identify and prove the location of testis and/or anorchia without postoperative complication : 10 intraabdominal testes (59%), 3 intracanalicular (18%), 4 anorchia (23%). 2. Among 10 intraabdominal testes 5 testes were brought down by transabdominal orchiopexy, 3 testes by Fowler-Stephens method, and 1 testis by staged orchiopexy and remaining testis were removed. 3. Among 3 intracanalicular testes 2 testes were brought down by transabdominal orchiopexy and one testis was removed. 4. Follow up testicular examination of fixed testes revealed no testicular atrophy in all transabdominal orchiopexed testes and no testicular atrophy in 1 of 3 testes which were performed by Fowler-Stephens method.
Atrophy ; Cryptorchidism ; Follow-Up Studies ; Humans ; Incidence ; Male ; Orchiopexy ; Postoperative Complications ; Testis*

To compare the efficacy of Stamey with that of Raz procedure in the correction of stress urinary incontinence, we studied retrospectively 43 patients who underwent either procedure at our institution between January, 1989 and June, 1994. Of 43 Patients were 23 underwent Stamey and 20 underwent Raz procedures. Patient's characteristics of the 2 groups were similar, but mean operative time was 107 minutes in Stamey and 76 minutes in Raz procedure(P<0.05), a care rate was obtained postoperatively in 65y. of the patient in Stamey and in 85% in Raz procedure(P<0.05). Postoperative complications were similar in 13.5% of the patients in Stamey and in 12.5% in Raz procedure. Although most predictive factors were not associated with cure or failure in our series, the postoperative cure rate was significantly higher in the group with urinary retention of more than a week. It is thought that Raz procedure is more safe and accurate than Stamey procedure by its shorter operation time and higher success rate(P<0.05). although patient's satisfaction with postoperative morbidity is similar between Stamey and Raz procedure.
Humans ; Operative Time ; Postoperative Complications ; Retrospective Studies ; Urinary Incontinence* ; Urinary Retention

Intravesical Bacillus Calmette-Guerin(BCG) Has been shown to be effective therapy and prophylaxis against recurrent tumor in patients with superficial bladder cancer(stages O and A), including carcinoma in situ. Tice-Chicago strain bacillus Calmette-Guerin was used to treat superficial transitional cell carcinoma of the bladder in 26 patients between July, 1985 and March, 1988. A variety of different BCG treatment regimens have been used that vary in intensity. In general, treatment results have been more favorable with intensive regimens. However, the toxicity also has been substantially greater with intensive regimens. The optimal regimen has yet to be determined. Our treatment regimen of 120mg. Tice-Chicago strain BCG weekly for 6 weeks and then monthly for 3 months was well tolerated. 20 patients had a complete response and 6 patients had a tumor recurrence at 21 months mean follow-up, resulting in 77% of response rate. Side effects during or shortly after treatment were minor and self- limiting in the majority of patients(fever, bladder irritability and hematuria). This experience supports the efficacy of bacillus Calmette-Guerin as a cost-effective, well- tolerated treatment modality for patients with superficial transitional cell carcinoma of the bladder.
Bacillus ; Carcinoma in Situ ; Carcinoma, Transitional Cell* ; Follow-Up Studies ; Humans ; Mycobacterium bovis ; Recurrence ; Urinary Bladder Neoplasms ; Urinary Bladder*